ArticleScientific reports2025
A GEANT4 Monte Carlo simulation study for the computation of output factors and out-of-field dosimetry in breast IOERT.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The goal of breast Intraoperative Electron Radiation Therapy (IOERT) is to deliver a uniform single fraction dose of 10-25 Gy to a surgically exposed volume of tissue at risk (tumor bed) while minimizing exposure to surrounding healthy tissue, with the patient under anesthesia. Currently, all the necessary information for the geometric and physical treatment arrangement is collected during the commissioning phase, when a preliminary dosimetric characterization of the accelerator is performed for clinical use in accordance with international protocols. During this process, output factors (OFs)-correction factors that account for dose differences relative to the reference condition-are measured. Therefore, since treatment plans rely exclusively on the OF and experimental measurements can be affected by large errors (on the order of 30%), a tuned Monte Carlo model provides a valuable tool for treatment validation. It is particularly valuable for evaluating quantities that are difficult to measure directly, such as dose variations resulting from shielding disk misalignment (to protect underlying healthy tissue) or out-of-field exposure to organs at risk in complex clinical scenarios (e.g., patients with implantable electronic devices or during pregnancy).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.